600666.SH
奥瑞德
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 3.38
−2.87%Margins
Gross margin
15.1%
EBITDA margin
63.1%
EBIT margin
35.7%
Net margin
28.7%
FCF margin
-26.2%
12.8%
Return on equity
6.3%
Return on assets
11.6%
Return on invested capital
0.22x
Asset turnover
CNY 37.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026